Herantis Pharma Oyj : Managers' Transactions – Craig Cook
Herantis Pharma Plc
Company release 30 Apr 2021 at 1:00pm EET
Herantis Pharma Oyj – Managers’ Transactions
____________________________________________
Person subject to the notification requirement
Name: Cook, Craig
Position: CEO
Issuer: Herantis Pharma Plc
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 743700W4CQVYAT3WKK38_20210422225636_3
____________________________________________
Transaction date: 2021-04-29
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: 2021 option rights in Herantis Pharma Plc
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
Transaction details
(1): Volume: 439,000 Unit price: 0.00 EUR
Aggregated transactions
(1): Volume: 439,000 Volume weighted average price: 0.00 EUR
____________________________________________
Further information:
Julie Silber/Gabriela Urquilla
Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19
Email:ir@herantis.com
Certified Advisor: UB Securities Ltd, Finland: +358 9 25 380 225, Sweden: +358 40 5161400
Company website: www.herantis.com
Distribution:
Main media
www.herantis.com